A 65 year old healthy man, with no family history of prostate cancer, had a routine PSA of 4.7 ug/L. His digital rectal examination was normal. He became anxious and depressed. A transrectal ultrasound guided biopsy showed a single microfocus of prostatic intraepithelial neoplasia. He remains dispirited. A new disease entity was identified and termed keep reading
Today’s world of prostate cancer (PCa) is a far cry from what it was in your dad’s day. New knowledge about the disease includes a better understanding of prostate anatomy, PCa genomics, the behavior of cancer cells, the role of lifestyle, etc. However, some old beliefs still linger. It’s time to put them to rest. keep reading
Prostate cancer is a slow-growing disease associated with aging, though younger men may develop more aggressive forms. Another process also associated with aging is dementia, which means declining mental and cognitive function. The incidence of both conditions begins to increase from age 65 onward. The most common treatment recommended for men with low-to-intermediate risk prostate keep reading
Men suspected of having prostate cancer based on rising PSA or abnormal DRE are typically sent for a transrectal ultrasound (TRUS) guided biopsy using 12 or more needles. At least 30% of TRUS biopsies miss the disease that is present, not to mention the possible side effects of the biopsy itself. What happens next? The keep reading
Let’s begin with the assurance that doctors deeply want to cure their prostate cancer patients. Whether we are urologists, radiologists or oncologists, this is our most important goal. To fulfill that goal, we offer the treatments for which we are best trained. Urologists are surgeons, so in their specialty cutting out the entire prostate (with keep reading
This site uses cookies to analyze traffic and user behavior, protect your privacy, and provide you with the best user experience. Learn more.